Neoleukin is the top competitor of ImmunityBio. Neoleukin is a Public company that was founded in Seattle, Washington in 2018. Like ImmunityBio, Neoleukin also operates in the Biotechnology sector. Neoleukin has 499 fewer employees vs. ImmunityBio.
Nektar Therapeutics is seen as one of ImmunityBio's biggest rivals. Nektar Therapeutics was founded in San Francisco, California} in 1990. Like ImmunityBio, Nektar Therapeutics also competes in the Pharmaceuticals & Biotechnology space. Compared to ImmunityBio, Nektar Therapeutics generates $111.2M less revenue.